CFA Induced Inflammatory Pain
Chemotherapy-Induced Neuropathic Pain
Diabetes-Induced Neuropathic Pain
EAE
MIA Induced Osteoarthritis
Neurite Outgrowth Assay
Neurodegeneration Screening Assay
Neuroma
Parkinson's Disease
Peripheral Nerve Injury
Neuropathic Pain
Post-Operative Pain
Spinal Cord Injury
Stroke and Ischemia
Wound Healing
Apr 30, 2024by MD Biosciences
Spinal cord injuries can lead to a range of complications, including sensory impairments, severe...
Apr 4, 2024by MD Biosciences
In preclinical efficacy studies, several factors are often overlooked, and it is important to evaluate variables like...
Mar 27, 2024by MD Biosciences
Increase value early in drug development with Biomarkers
Biomarkers have emerged as transformative tools in...
Mar 18, 2024by MD Biosciences
The goal of the preclinical development process is to help predict clinical efficacy, emphasizing the importance of...
Mar 5, 2024by MD Biosciences
HTX-011 Breakthrough in Pain Management
ZYNRELEF, the commercial name for HTX-011, is the first and only FDA-approved
.png?width=600&height=600&name=Nerve%20injury%20datasheet%20(1).png)
.png?width=600&height=600&name=Wound%20Healing%20datasheet%20(1).png)